Showing results (931-940 of 26,311) with videos related to
Sort By:
Pageof 2,632
Bioorganic & Medicinal Chemistry Letters|December 27, 2017
Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitorsAndrii Monastyrskyi, Simon Bayle, Victor Quereda, et al.Bioorganic & Medicinal Chemistry Letters|December 27, 2017
Design, synthesis, and evaluation of novel inhibitors for wild-type human serine racemaseSatoyuki Takahara, Kiyomi Nakagawa, Tsugumi Uchiyama, et al.Bioorganic & Medicinal Chemistry Letters|March 1, 2018
Biosynthesis and in vitro enzymatic synthesis of the isoleucine conjugate of 12-oxo-phytodienoic acid from the isoleucine conjugate of α-linolenic acidAkira Uchiyama, Takaomi Yaguchi, Hiroyuki Nakagawa, et al.Bioorganic & Medicinal Chemistry Letters|March 15, 2018
A novel templates of piperazinyl-1,2-dihydroquinoline-3-carboxylates: Synthesis, anti-microbial evaluation and molecular docking studiesSaleha Banu, Rajitha Bollu, Mohammad Naseema, et al.Bioorganic & Medicinal Chemistry Letters|March 15, 2018
Discovery of N-aryl-N'-pyrimidin-4-yl ureas as irreversible L858R/T790M mutant selective epidermal growth factor receptor inhibitorsFusheng Zhou, Liang Zhang, Yunzhou Jin, et al.Bioorganic & Medicinal Chemistry Letters|March 15, 2018
First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strainBoshi Huang, Xinhao Liu, Ye Tian, et al.Bioorganic & Medicinal Chemistry Letters|December 8, 2018
Triazolopyrimidine and triazolopyridine scaffolds as TDP2 inhibitorsCarlos J A Ribeiro, Jayakanth Kankanala, Jiashu Xie, et al.Bioorganic & Medicinal Chemistry Letters|December 8, 2018
Synthesis and evaluation of thieno[3,2-d]pyrimidine derivatives as novel FMS inhibitorsYu-Yon Kim, Jaeyul Choi, Kyungjin Choi, et al.Bioorganic & Medicinal Chemistry Letters|December 28, 2020
Novel BuChE-IDO1 inhibitors from sertaconazole: Virtual screening, chemical optimization and molecular modeling studiesYou Zhou, Xin Lu, Chenxi Du, et al.Bioorganic & Medicinal Chemistry Letters|December 28, 2020
Characterization of ibrutinib as a non-covalent inhibitor of SRC-family kinasesMing Guo, Shuyan Dai, Daichao Wu, et al.Pageof 2,632